Powder: -20°C for 3 years | In solvent: -80°C for 1 year
93-O17O is a chalcogen-containing cationic lipidoid.1,2It has been used in the generation of lipid nanoparticles (LPNs). LPNs containing 93-O17O localize to the spleen after intravenous injection into mice.1LPNs containing 93-O17O have been used for the delivery of Cre recombinase and ribonucleoproteins for genome editing in mice and for the intratumoral delivery of cGAMP to enhance cross-presentation of tumor antigens.3,2
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | 35 days | $ 253.00 | |
10 mg | 35 days | $ 480.00 | |
25 mg | 35 days | $ 987.00 |
Description | 93-O17O is a chalcogen-containing cationic lipidoid.1,2It has been used in the generation of lipid nanoparticles (LPNs). LPNs containing 93-O17O localize to the spleen after intravenous injection into mice.1LPNs containing 93-O17O have been used for the delivery of Cre recombinase and ribonucleoproteins for genome editing in mice and for the intratumoral delivery of cGAMP to enhance cross-presentation of tumor antigens.3,2 |
Synonyms | 93-O17O |
Molecular Weight | 750.15 |
Formula | C44H83N3O6 |
CAS No. | 2227214-78-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Chloroform: 25 mg/mL
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
93-O17O 2227214-78-8 93O17O 93-O-17O 93 O17O inhibitor inhibit